When combined, a novel LSD1 inhibitor and an existing therapy enhance each other's anti-cancer effects
A Medical University of South Carolina (MUSC) research team has developed novel compounds that show early promise at fighting the rare pediatric cancer neuroblastoma when paired with the existing anti-cancer drug bortezomib ...
Dec 14, 2022
0
47
